Assessment of Knowledge, Attitudes and Practices Regarding SMA Carrier Screening and Newborn Screening Programs Among Physicians in Tertiary Healthcare Institutions

Öz

Aim: This study aims to evaluate the knowledge, attitudes, and behaviors of physicians in tertiary healthcare institutions regarding SMA carrier and newborn screening programs. Materials and Methods: This study is cross-sectional and descriptive in nature. After obtaining ethical approval, it was conducted between 17.07.2024 and 16.08.2024 with the participation of 80% of physicians working in the internal medicine departments of XXXXXX. Results: In this study, the average age of physicians was 27.92 ±3.63 years, with 61.2% being female. Physicians with chronic diseases have significant knowledge about NSP and have significant scores of 50 and above on the SMA knowledge scale. Married physicians, physicians who have children, and physicians who have information about SMA are significantly more likely to source information about NSP from physicians and healthcare professionals. Participants whose source of information about SMA is a physician and physicians who have information about NSP know the majority of NSP tests at a significant rate. It was determined that the knowledge level of physicians, especially those with chronic diseases, was high about NSP and SMA, which can be diagnosed early. Conclusion: We believe that it would be beneficial to focus on NSP training in medical school education, to organize courses on this subject for general practitioners, and to increase the quality of NSP training for internal medicine physicians in order to reach a sufficient level of NSP and SMA carrier screening in the society.

Anahtar Kelimeler

• NEWBORN SCREENİNG
• PHYSICIANS
• SPINAL MUSCULAR ATROPHY

Üçüncü Basamak Sağlık Kurumlarında Görevli Hekimlerde SMA Taşıyıcılık ve Yenidoğan Tarama Programlarına Yönelik Bilgi, Tutum ve Uygulamaların Değerlendirilmesi

Öz

Amaç: Bu çalışma, üçüncü basamak sağlık kurumlarında görev yapan hekimlerin SMA taşıyıcılık ve yenidoğan tarama programlarına yönelik bilgi, tutum ve davranışlarını değerlendirmeyi amaçlamaktadır. Gereç ve Yöntem: Bu çalışma kesitsel ve tanımlayıcı niteliktedir. Etik onay alındıktan sonra, 17.07.2024 - 16.08.2024 tarihleri arasında, XXXX'deki dahili tıp birimlerinde çalışan hekimlerin %80’inin katılımıyla gerçekleştirilmiştir. Bulgular: Çalışmada hekimlerin ortalama yaşı 27,92 ±3,63 yıl olup, %61,2’si kadındır. Kronik hastalığı olan hekimlerin YTP hakkında anlamlı düzeyde bilgiye sahip oldukları ve SMA bilgi ölçeğinde 50 ve üzeri anlamlı puanlara sahip oldukları görülmüştür. Evli olan, çocuk sahibi olan ve SMA hakkında bilgi sahibi olan hekimler, YTP hakkında bilgi kaynaklarını anlamlı olarak daha çok hekimlerden ve sağlık çalışanlarından edinmektedir. SMA hakkındaki bilgi kaynağı bir hekim olan katılımcılar ile YTP hakkında bilgi sahibi olan hekimler, YTP kapsamındaki testlerin çoğunu anlamlı düzeyde bilmektedir. Özellikle kronik hastalığı olan hekimlerin, erken tanı konulabilen YTP ve SMA hakkında yüksek düzeyde bilgiye sahip olduğu belirlenmiştir. Sonuç: Toplumda yeterli düzeyde YTP ve SMA taşıyıcılık taramasına ulaşabilmek için, tıp fakültesi eğitiminde YTP konusuna daha fazla yer verilmesinin, pratisyen hekimlere yönelik bu konuda kurslar düzenlenmesinin ve dahili tıp hekimlerinin YTP eğitim kalitesinin artırılmasının faydalı olacağı kanaatindeyiz.

Anahtar Kelimeler

• YENİDOĞAN TARAMASI
• HEKİMLER
• SPİNAL MUSKULER ATROFİ

Kaynakça

1. Mallmann MB, Tomasi YT, Boing AF. Neonatal screening tests in Brazil: Prevalence ratesand regional and socioeconomic inequalities. Jornal de Pediatria 2020;96(4);487 494.
2. Republic of Turkey Ministry of Health. (2022). Newborn Metabolic and Endocrine Disease Screening Program. Republic of Turkey Ministry of Health, General Directorate of Public Health. Access Date: 05.09.2024. https://hsgm.saglik.gov.tr/tr/ tarama-programlari/ntp.html
3. Republic of Turkey Ministry of Health. Pre- Marital Spinal Muscular Atrophy (SMA). Carrier Screening Program. General Directorate of Public Health. 2021. https:// hsgm.saglik.gov.tr/tr/cocukergen-tp-liste/ evlilikoncesi-spinal-muskuler-atrofi-smatasiyici- tarama-programi.html.
4. Schorling DC, Pechmann A, Kirschner J. Advances in treatment of spinal muscular atrophy–new phenotypes, new challenges, new implications for care. Journal of neuromuscular diseases, 2020;7(1), 1-13.
5. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J. Correlation between severity and SMN protein level in spinal muscular atrophy. Nature Genetics, 1997;16(3), 265- 269.
6. Ogbonmıde Tolu, et al. Gene therapy for spinal muscular atrophy (SMA): A review of current challenges and safety considerations for onasemnogene abeparvovec (Zolgensma). Cureus, 2023;15.3.
7. Republic of Turkey Ministry of Health. Spinal Muscular Atrophy (SMA) Clinical Protocol 2022. AccessDate:04.09.2024. https://shgmargestddb.saglik.gov.tr/Eklenti/ 43881/0/smakp190822pdf.pdf.
8. Erbay A, Yıldız D. Validity and reliability study of the Turkish version of the “Mother’s Knowledge and Attitudes Scale on Newborn Screenings” [master’s thesis]. Ankara: Sağlık Bilimleri Üniversitesi Gülhane Sağlık Bilimleri Enstitüsü; 2020.

9. Şahin M, Karaman ST, Basat O. Evlilik öncesi kişilerin SMA taşıyıcılığı taraması hakkında bilgi, tutum ve davranışları. Turk J Fam Pract. 2024;28(1):11-17.
10. Republic of Turkey Ministry of Health, Turkish Public Health Institution, Department of Child and Adolescent Health. (2022). Newborn Metabolic and Endocrine Disease Screening Program (NSP). Accessed Date: 10.08.2022.https://hsgm. saglik.gov.tr/tr/cocukergen-tpliste/yenidogan_ tarama_programi.html
11. Wood SL, Brewer F, Ellison R, Biggio JR, Edwards RK. Prenatal carrier screening for spinal muscular atrophy. Am J Perinatol. 2016;33(12):1211-7.
12. Padilla CD, Therrell BL, Working Group of the Asia Pacific Society for Human Genetics on Consolidating Newborn Screening Efforts in the Asia Pacific Region. (2012). Consolidating newborn screening efforts in the Asia Pacific region. Journal of Community Genetics, 3(1), 35-45.
13. IJzebrink A, van Dijk T, Franková V, Loeber G, Kožich V, Henneman L, Jansen M. (2021). Informing Parents about Newborn Screening: A European Comparison Study. International Journal of Neonatal Screening, 7(1), 13.
14. Evaluation of Factors Affecting Mothers' Knowledge and Attitudes Towards the Newborn Screening Program, Ordu University. J Nurs Stud 2023, 6(2), 311-318.
15. Fitzgerald C, Heery E, Conneally N, Linnane B, George S, Fitzpatrick P. An evaluation of pregnant women's knowledge and attitudes about newborn bloodspot screening. Midwifery, 2017;45, 21–27.
16. Knowledge, Attitudes, and Behaviors of Individuals Before Marriage Regarding SMA Carrier Screening, Turkish J Family Practice.2024;28(1):11-17.
17. Yücel Z, Yüksel EB. Spinal Muscular Atrophy: Current Developments in Diagnosis, Screening, and Treatment. Journal of General Health Sciences. 2023;5(2), 275- 287.